The study protocol for a non-randomized controlled clinical trial using a genotype-guided strategy in a dataset of patients who undergone percutaneous coronary intervention with stent
MetadataShow full item record
AuthorDávila Fajardo, Cristina Lucía; Sánchez Ramos, Jesús Gabriel; Díaz Villamarín, Xando; Martínez González, Luis Javier; Toledo Frías, Pablo; Martínez Huertas, Susana; Burillo Gómez, Francisco; Caballero Borrego, Juan; Bautista Pavés, Alicia; Marín Guzmán, María Carmen; Ramírez Hernández, José Antonio; Correa Vilches, Concepción; Cabeza Barrera, José
Clinical trial protocol
C. L. Dávila-Fajardo et al. The study protocol for a non-randomized controlled clinical trial using a genotype-guided strategy in a dataset of patients who undergone percutaneous coronary intervention with stent. Data in Brief 10 (2017) 518–524 [https://doi.org/10.1016/j.dib.2016.12.019]
SponsorshipMinistry of Health of Government of Andalusia PI-057/2012
This article contains data related to the research article entitled “Results of genotype–guided antiplatelet therapy in patients undergone percutaneous coronary intervention with stent” (J. Sánchez-Ramos, C.L. Dávila-Fajardo, P. Toledo Frías, X. Díaz Villamarín, L.J. Martínez-González, S. Martínez Huertas, F. Burillo Gómez, J. Caballero Borrego, A. Bautista Pavés, M.C. Marín Guzmán, J.A. Ramirez Hernández, C. Correa Vilches, J. Cabeza Barrera, 2016) (1). This data article reports, for the first time, about the non-randomized clinical trial protocol that check if CYP2C19/ABCB1 genotype–guided strategy in which the choice of antiplatelet therapy is based on the genetic test, reduces the rates of cardiovascular events and bleeding compared to a non-tailored strategy in patients undergone percutaneous coronary intervention (PCI) with stent. The data included in this article are: design and setting of the study, study population, inclusion and exclusion criteria, definition of the intervention, objectives, variables (baseline characteristics and during the follow-up), study procedures, collection and treatment of the biological sample, genotyping, withdrawal criteria, sample size, statistic analysis, ethical aspects, information sheet and consent form. The authors confirm that this study has been registered in Eudra CT (Eudra CT: 2016-001294-33).